SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-15-000029
Filing Date
2015-05-04
Accepted
2015-05-04 16:29:38
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2015q110-q.htm 10-Q 1031032
2 EXHIBIT 10.1 vrtx10q_exhibit101.htm EX-10.1 55392
3 EXHIBIT 10.2 vrtx10q_exhibit102.htm EX-10.2 50339
4 EXHIBIT 31.1 a2015q110-q_exhibit311.htm EX-31.1 14503
5 EXHIBIT 31.2 a2015q110-q_exhibit312.htm EX-31.2 14337
6 EXHIBIT 32.1 a2015q110-q_exhibit321.htm EX-32.1 11728
  Complete submission text file 0000875320-15-000029.txt   8156689

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vrtx-20150331.xml EX-101.INS 1315491
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20150331.xsd EX-101.SCH 46323
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20150331_cal.xml EX-101.CAL 82436
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20150331_def.xml EX-101.DEF 196409
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20150331_lab.xml EX-101.LAB 622050
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20150331_pre.xml EX-101.PRE 332817
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 15828822
SIC: 2834 Pharmaceutical Preparations